Radiation Oncology | Articles preview

The value of elective neck irradiation in management of esthesioneuroblastoma: a retrospective study based on propensity score matching
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-024-02539-x

This study aims to assess the clinical efficacy of elective neck irradiation (ENI) in patients with esthesineuroblastoma (ENB), a rare malignant neoplasm, who are clinically node-negative.

Crossword Puzzle: Answer Key
https://www.jvir.org/article/S1051-0443(24)00506-2/fulltext?rss=yes

By Richard Taus, MD; E-mail [email protected]

Crossword Puzzle
https://www.jvir.org/article/S1051-0443(24)00507-4/fulltext?rss=yes

By Richard Taus, MD; E-mail [email protected]

Percutaneous Puncture of a Fetoscopic Endoluminal Tracheal Occlusion Balloon
https://www.jvir.org/article/S1051-0443(24)00496-2/fulltext?rss=yes

Fetoscopic endoluminal tracheal occlusion (FETO) is an investigational therapy to induce lung volume increase and development and improves the survival in patients with severe congenital diaphragmatic hernia (CDH). Elective balloon removal 4–7 weeks after placement reduces the development of surfactant deficiency, risk of preterm delivery, and potential need for emergent removal during delivery or on placental bypass. Failure to deflate and retrieve the balloon can result in iatrogenic neonatal death.

Percutaneous Exchange of Endoscopically Placed Gastrostomy-Jejunostomy Tube Leading to Intussusception
https://www.jvir.org/article/S1051-0443(24)00470-6/fulltext?rss=yes

Geospatial and Socioeconomic Disparities in Access to IR Care in the United States
https://www.jvir.org/article/S1051-0443(24)00386-5/fulltext?rss=yes

To determine and analyze the geographic distribution of interventional radiologists in the United States to identify populations with decreased access to interventional radiology (IR) care.

Forthcoming Articles
https://www.jvir.org/article/S1051-0443(24)00592-X/fulltext?rss=yes

Corrigendum
https://www.jvir.org/article/S1051-0443(24)00385-3/fulltext?rss=yes

Corrigendum to “Geospatial and Socioeconomic Disparities in Access to IR Care in the United States”

The Burden of Insurance Prior Authorization on Cancer Care: A Review of Evidence from Radiation Oncology
https://www.advancesradonc.org/article/S2452-1094(24)00217-3/fulltext?rss=yes

Despite its high cost-effectiveness, radiation oncology faces the greatest prior authorization (PA) burden of any medical specialty. Insurance denials and resulting treatment delays have been documented across several treatment modalities, including stereotactic body radiation, intensity-modulated radiation, and proton therapy. While insurance companies suggest that PA is intended to control healthcare spending and ensure the implementation of evidence-based practice, the number of radiation treatment plans reviewed by the PA process that result in changes is quite low.

Hologic Acquires Gynesonics to Strengthen Existing Gynecological Surgical Business
https://www.medimaging.net/industry-news/articles/294802844/hologic-acquires-gynesonics-to-strengthen-existing-gynecological-surgical-business.html

Hologic has signed a definitive agreement to acquire Gynesonics for approximately USD 350 million, strengthening its portfolio of medical technologies...

PET Scan Based on Lizard Saliva Reliably Detects Benign Tumors in Pancreas
https://www.medimaging.net/nuclear-medicine/articles/294802833/pet-scan-based-on-lizard-saliva-reliably-detects-benign-tumors-in-pancreas.html

A new PET scan has shown promise in reliably detecting benign tumors in the pancreas that cannot be detected by...

Cone-beam computed tomography-based online adaptive radiotherapy of esophageal cancer: first clinical experience and dosimetric benefits
https://www.advancesradonc.org/article/S2452-1094(24)00219-7/fulltext?rss=yes

Radiotherapy (RT) plays a key role in the management of esophageal cancer (EC). However, toxicities due to proximity of organs at risk (OAR) and daily target coverage caused by interfractional anatomical changes are of concern. Daily online adaptive radiotherapy (oART) addresses these concerns and has the potential to increase OAR sparing and improve target coverage. We present the first clinical experience and dosimetric investigations of CBCT-based oART in EC using the ETHOS platform.Methods: Treatment fractions of the first 10 EC patients undergoing CBCT-based oART at our institution were retrospectively analyzed.

Global Statement Defining Interventional Radiology—Have We Reached the Tipping Point?
https://www.jvir.org/article/S1051-0443(24)00646-8/fulltext?rss=yes

Interventional Radiology Physician Compensation at U.S. Medical Schools: Trends and Segments
https://www.jvir.org/article/S1051-0443(24)00653-5/fulltext?rss=yes

The aim of this study was to assess recent US medical school trends in compensation for academic interventional radiologists (IR) and compensation characteristics based on rank, sex and race/ethnicity.

Smith+Nephew and JointVue Partner on Ultrasound Preoperative Planning in Robotics-Assisted Surgery
https://www.medimaging.net/industry-news/articles/294802824/smithnephew-and-jointvue-partner-on-ultrasound-preoperative-planning-in-robotics-assisted-surgery.html

Smith+Nephew has entered into a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the...

Time to Next Systemic Therapy after Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Castrate-Resistant Prostate Cancer
https://www.advancesradonc.org/article/S2452-1094(24)00218-5/fulltext?rss=yes

Patients with metastatic castrate-resistant prostate cancer (CRPC) with progressive disease generally require a change or escalation in systemic therapy. For patients with limited1-3 sites of progressive disease (oligoprogression), metastasis-directed therapy with stereotactic body radiation therapy (SBRT) may allow a longer interval before next line systemic therapy.

Radiation Pneumonitis after Yttrium-90 Radioembolization: A Systematic Review
https://www.jvir.org/article/S1051-0443(24)00650-X/fulltext?rss=yes

The guideline regarding the maximum tolerated lung dose for Yttrium-90 (Y90) radioembolization is an expert opinion (level 5 evidence) based on a case series of 5 patients and recommends keeping the absorbed radiation dose to the lungs below 30 Gy per treatment and 50 Gy in a lifetime to prevent radiation pneumonitis (RP). The current understanding of the risks of RP is minimal despite its debilitating nature and high mortality rate. This review evaluates the available evidence of lung dosimetry and RP.

Radiation Pneumonitis- Why Are We Still Guessing?
https://www.jvir.org/article/S1051-0443(24)00651-1/fulltext?rss=yes

Embolization before ablation of T1b renal cell carcinoma (EMBARC)
https://www.jvir.org/article/S1051-0443(24)00652-3/fulltext?rss=yes

AAPM Group Looking for Volunteers
https://w3.aapm.org/ads/committee_classifieds/classifieds.php?positionId=6572

Task Group No. 36.B: Fetal Dose Considerations in Radiation Therapy (TG36.B) has 4-6 position(s) open for the Role of Member. Learn More & Apply: